» Articles » PMID: 15636298

Impact of Ventilator-associated Pneumonia on Resource Utilization and Patient Outcome

Overview
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To assess the effect of ventilator-associated pneumonia on resource utilization, morbidity, and mortality.

Design: Retrospective matched cohort study based on prospectively collected data.

Setting: Medical intensive care unit of a university teaching hospital.

Patients: Case-patients were all patients receiving mechanical ventilation for 48 hours or more who experienced an episode of ventilator-associated pneumonia. Control-patients were matched for number of discharge diagnoses, duration of mechanical support before the onset of pneumonia among case-patients, age, admission diagnosis, gender, and study period.

Results: One hundred six cases of ventilator-associated pneumonia were identified in 452 patients receiving mechanical ventilation. The matching procedure selected 97 pairs. Length of stay in the intensive care unit and duration of mechanical ventilation were greater among case-patients by a mean of 7.2 days (P< .001) and 5.1 days (P< .001), respectively. Median costs were $24,727 (interquartile range, $18,348 to $39,703) among case-patients and $17,438 (interquartile range, $12,261 to $24,226) among control-patients (P < .001). The attributable mortality rate was 7.3% (P = .26). The attributable extra hospital stay was 10 days with an extra cost of $15,986 per episode of pneumonia.

Conclusion: Ventilator-associated pneumonia negatively affects patient outcome and represents a significant burden on intensive care unit and hospital resources.

Citing Articles

Development of a Weighted-Incidence Syndromic Combination Antibiogram (WISCA) to guide empiric antibiotic treatment for ventilator-associated pneumonia in a Mexican tertiary care university hospital.

Briseno-Ramirez J, Gomez-Quiroz A, Avila-Cardenas B, De Arcos-Jimenez J, Perales-Guerrero L, Andrade-Villanueva J BMC Infect Dis. 2025; 25(1):307.

PMID: 40038606 PMC: 11877913. DOI: 10.1186/s12879-025-10677-0.


Epidemiological characteristics of ventilator-associated pneumonia in neurosurgery: A 10-year surveillance study in a Chinese tertiary hospital.

Yu Z, Li X, Lv C, Tian Y, Suo J, Yan Z Infect Med (Beijing). 2024; 3(3):100128.

PMID: 39314809 PMC: 11417690. DOI: 10.1016/j.imj.2024.100128.


Increasing the precision of simulated percutaneous dilatational tracheostomy-a pilot prototype device development study.

Haron A, Li L, Davies E, Alexander P, McGrath B, Cooper G iScience. 2024; 27(3):109098.

PMID: 38380258 PMC: 10877963. DOI: 10.1016/j.isci.2024.109098.


Impact of a multifaceted prevention program on ventilator-associated pneumonia including selective oropharyngeal decontamination.

Landelle C, Nocquet Boyer V, Abbas M, Genevois E, Abidi N, Naimo S Intensive Care Med. 2018; 44(11):1777-1786.

PMID: 30343312 PMC: 6244525. DOI: 10.1007/s00134-018-5227-4.


Antimicrobial Stewardship Opportunities in Critically Ill Patients with Gram-Negative Lower Respiratory Tract Infections: A Multicenter Cross-Sectional Analysis.

Claeys K, Zasowski E, Trinh T, Lagnf A, Davis S, Rybak M Infect Dis Ther. 2017; 7(1):135-146.

PMID: 29164489 PMC: 5840098. DOI: 10.1007/s40121-017-0179-5.